Ruediger Weseloh - Info zur Person mit Bilder, News & Links



	Nyrada Merck Director Non-Executive Senior Board Business Development Marcus Frampton Aktie Company Nyrada Inc Heiner Hoppmann

News

Nyrada Announces Milestone Achieved in Brain Injury Program; Strong...

kalkinemedia.com

Ruediger Weseloh, Non-Executive Director. Dr Weseloh has almost 13 years of Business Development experience in the German Merck KGaA ...

57% Reduction in Total Cholesterol from Nyradas NYX ...

www.finnewsnetwork.com.au

— ... Mr Marcus Frampton (Non-Executive Director); Mr Peter Marks (Non-Executive Director); Dr Ruediger Weseloh (Non-Executive Director) ... › ...

Update on Progress in Nyrada Programs | Finance News Network

www.finnewsnetwork.com.au

Media Release from Nyrada on

Börsengänge: Epigenomics rutscht vor Erstnotiz unter Preisspanne -...

www.faz.net

Am 16. Juli will sich die Biotech-Firma Epigenomics erstmals im Prime Standard notieren lassen. Doch ob der Börsengang erfolgreich sein...

Netzwerk-Profile

LinkedIn: Ruediger Weseloh | LinkedIn

Sehen Sie sich das berufliche Profil von Ruediger Weseloh (Deutschland) auf LinkedIn an. LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- ...

LinkedIn: Ruediger Weseloh | LinkedIn

Ruediger Weselohs berufliches Profil anzeigen LinkedIn ist das weltweit größte berufliche Netzwerk, das Fach- und Führungskräften wie Ruediger Weseloh ... Es fehlt: dinslaken

Ruediger Weseloh - Business News

www.businessnews.com.au

› ...

Interessen

News | CYTOTOOLS Stock Price Today | Analyst Opinions

markets.businessinsider.com

Ruediger Weseloh, Member-Supervisory Board. Matthias Hoffmann, Member-Supervisory Board. Bernhard Seehaus, Member-Supervisory Board ... › ...

Ausbildung

Ruediger Weseloh - Biografie - MarketScreener.com

de.marketscreener.com

› biography

Dokumente zum Namen

Oct 19, Biotech Daily

www.biotechdaily.com.au

— Christopher Cox, Marcus Frampton, Ruediger Weseloh and Dr Dixon and approve the 10 percent placement capacity. › backissues

Video & Audio

Nyrada (ASX:NYR) CEO James Bonner presenting at Meet ...

stocksdownunder.com

— In addition, Dr. Ruediger Weseloh, who's a neuroscientist, he's PhD in Neuroscience. He is also a senior business development director for ... › video

Sonstiges

(1 - 20 von 21

–alle anzeigen

)

Ruediger Weseloh | Berufsprofil - LinkedIn

www.linkedin.com

Sehen Sie sich das Profil von Ruediger Weseloh auf LinkedIn an, dem weltweit größten beruflichen Netzwerk. Ruediger Weseloh hat 1 Job im Profil angegeben. Sehen Sie sich auf LinkedIn das vollständige Profil an und erfahren Sie mehr über die Kontakte von Ruediger Weseloh und über Jobs bei ähnlichen ... Missing: otterstadt

Board of Directors | Nyrada - Biotechnology Company

www.nyrada.com

Nyrada Inc is a new US biotechnology company focusing on innovative, first-in-class, small molecule drugs in non-oncology fields.

Annual report: BIOXXMED AG

produkte.erstegroup.com

Ruediger Weseloh. Member of Supervisory Board. Heiner Hoppmann. Member of Supervisory Board. Matthias Hoffmann. Member of Supervisory Board. › res › PdfRenderer

Benjamin Evison - Biographie

www.zonebourse.com

Presently, Benjamin Evison occupies the position of Chief Scientific Officer at Nyrada, Inc. Dr. Evison received an undergraduate degree and a doctorate from...

BIOXXMED AG Aktie DE000A0KFRJ1 - Consorsbank

www.consorsbank.de

Dr. Ruediger Weseloh. Heiner Hoppmann. Matthias Hoffmann. Beteiligt an. Daten nicht verfügbar. Hilfe & Kontakt · Karte sperren. Chat offline. › web › Aktie › Firmenprofil

MERCK AKTIE Unternehmensprofil | Aktionärsstruktur |

www.finanzen.net

Ruediger Weseloh Senior Director-Business Development. Sascha Held Vice Chairman-Supervisory Board. Scott Filosi Head-Global Market Access & Pricing. › unternehmensprofil › merck

CYTOTOOLS AKTIE Unternehmensprofil | Aktionärsstruktur | A0KFRJ

www.finanzen.net

CYTOTOOLS AKTIE Profil - hier finden Sie alle Informationen über CYTOTOOLS AKTIE wie z.B. Management, Profil, Aktionärsstruktur und Bilanzdaten.

Merck Unternehmensprofil - FINANZEN.AT

www.finanzen.at

Ruediger Weseloh Senior Director-Business Development. Sascha Held Vice Chairman-Supervisory Board. Scott Filosi Head-Global Market Access & Pricing. › Aktien › Merck-Aktie

T5O | bioXXmed AG Stock Overview (Germany: Xetra ) | Barron's

www.barrons.com

Complete bioXXmed AG stock information by Barron's. View real-time T5O stock price and news, along with industry-best analysis.

NYR Insider Trading Activity | Nyrada Insider Buys and Sells

www.marketbeat.com

Which Nyrada insiders have been selling company stock? The following insider sold NYR shares in the last 24 months: Ruediger Weseloh (A$26, ). › ASX

NYR | Nyrada Inc. Profile - MarketWatch

www.marketwatch.com

Ruediger Weseloh is on the board of CytoTools AG and Nyrada, Inc. and Senior Director-Global Business Development at Merck Healthcare KGaA and ... › nyr

Nyrada Company Profile - Office Locations, Competitors ...

craft.co

Benny Evison, Chief Scientific Officer. Christopher Cox, Non-Executive Director. Ruediger Weseloh. Marcus Frampton. and 4 others. LocationsView all ... › nyrada

Nyrada Inc (ASX:NYR) - Shares, Dividends & News

www.intelligentinvestor.com.au

Mr Ruediger Weseloh, Non-Executive Director, 4 Jun Mr Christopher Cox, Non-Executive Director, 7 Nov Mr Marcus Frampton, Non-Executive Director ... › ...

Nyrada Inc (ASX:NYR) Share Price - Market Index

www.marketindex.com.au

Mr Ruediger Weseloh, Non-Executive Director, Jun Mr Marcus Frampton, Non-Executive Director, Jun Mr David James Franks, Company Secretary, N/A. › ...

Nyrada Inc. (ASX:NYR) Share Price News - Motley Fool

www.fool.com.au

Mr Ruediger Weseloh, Non-Executive Director, Jun Mr Weseloh is a Senior Director of Business Development at Merck KgaA, Darmstadt, Germany, ... › tickers

T5O.XE Company Profile & Executives - bioXXmed AG

www.wsj.com

Ruediger Weseloh is on the board of CytoTools AG and Nyrada, Inc. and Senior Director-Global Business Development at Merck Healthcare KGaA and ... › XETR › ex... › MRK › exe...

bioXXmed AG Stock Overview (Germany: Frankfurt ) - T5O

www.barrons.com

Bruno Rosen MD. Member-Management Board. Bernhard Seehaus PhD. Member-Supervisory Board. Ruediger Weseloh PhD. Member-Supervisory Board. Heiner Hoppmann. › stocks

Speakers - Molecular Diagnostics Europe Conference - Cambridge...

www.clinicalgenomicsinformatics.com

Ruediger Weseloh, Ph.D., Senior Director, Head Strategic Transactions, Early-Stage Licensing, Merck KGaA. Stephen A. Williams, M.D., Ph.D., CMO, ...

bioXXmed Aktie (A0KFRJ,DE000A0KFRJ1) - Finanzen100

www.finanzen100.de

Aufsichtsrat. Dr. Manfred May (Aufsichtsratsvorsitzender). Dr. Bernhard Seehaus. Dr. Ruediger Weseloh. Heiner Hoppmann. Matthias Hoffmann. Schließen. › aktien

| Nyrada - Biotechnology Company

www.nyrada.com

Ruediger Weseloh Ph.D. Non-Executive Director. Rudiger joined Merck KGaA, Darmstadt, Germany, as a Senior Licensing Manager in Since then he held ...

Verwandte Suchanfragen zu Ruediger Weseloh

Sascha Held
Matthias Hoffmann
Heiner Hoppmann

Person "Weseloh" (1)
Vorname "Ruediger" (1336)
Name "Weseloh" (203)

sortiert nach Relevanz / Datum

Erweiterte Suche

Dossier exportieren

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z